$140.80
Today
as of Jul 27, 16:52 ET
Last 30 days
Recent Press Releases & News
Novanta Completes Acquisition of Riverpoint Medical From Arlington Capital Partners
Novanta Completes Acquisition of Riverpoint Medical
3 Reasons to Avoid NOVT and 1 Stock to Buy Instead
Overview
52-week range
$98
$172
58% of range
Avg surprise (last 3)
+5.1%
Avg reaction (last 2)
-0.4%
50% positive
Latest IV / EM
65%
EM ±13.5% · $140 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 11, 2026 | Mar/2026 | $0.81 | $0.78 | +3.9% | +9.5% | +1.2% | earnings |
| Fri Sep 26, 2025 | Sep 2025 | $0.30 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $0.76 | $0.74 | +2.7% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.74 | $0.68 | +8.8% | — | -1.9% | earnings |
| Fri Sep 27, 2024 | Sep 2024 | $0.53 | — | — | — | — | financials |
| Fri Jun 28, 2024 | Jun 2024 | $0.38 | — | — | — | — | financials |
| Fri Mar 29, 2024 | Mar 2024 | $0.41 | — | — | — | — | financials |
| Fri Sep 29, 2023 | Sep 2023 | $0.59 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.58 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | AMC | $0.82 | $0.76 | +7.9% |
Financials
Income statement (quarterly)
| Metric | Apr 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | $114M | — | $111M | $107M | $104M | — | $109M | $104M |
| Operating income | $28M | — | $22M | $15M | $32M | — | $33M | $26M |
| Net income | $21M | — | $11M | $4M | $21M | — | $19M | $14M |
| EPS (diluted) | $0.51 | — | $0.30 | $0.12 | $0.59 | — | $0.53 | $0.38 |
Balance sheet (quarterly)
| Metric | Apr 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $389M | $381M | $89M | $110M | $106M | $114M | $93M | $98M |
| Inventory | $193M | $188M | $180M | $168M | $145M | $145M | $154M | $160M |
| Total current assets | $787M | $783M | $468M | $462M | $434M | $434M | $437M | $425M |
| Total assets | $1.80B | $1.81B | $1.51B | $1.51B | $1.39B | $1.39B | $1.42B | $1.40B |
| Long-term debt | $201M | $213M | $446M | $454M | $385M | $412M | $453M | $477M |
| Total liabilities | $488M | $493M | $704M | $710M | $616M | $643M | $677M | $697M |
| Total equity | $1.31B | $1.31B | $801M | $801M | $770M | $746M | $742M | $702M |